GregoryStanleonPokrywkaMDFACP FNLA FASPC NCMP

PubMed

• 4 citations
  PCSK9 inhibitors: a non-statin cholesterol-lowering treatment option
  Gregory S. Pokrywka> ;Postgraduate Medicine. 2018 Feb 23
• 11 citations
  Managing to low-density lipoprotein particles compared with low-density lipoprotein cholesterol: A cost-effectiveness analysis
  John A. Rizzo, Peter J. Mallow, Heidi C. Waters, Gregory S. Pokrywka> ;Journal of Clinical Lipidology. 2013 Nov 1
• 12 citations
  Impact of triglycerides on lipid and lipoprotein biology in women.
  Thomas D. Dayspring, Gregory S. Pokrywka> ;Gender Medicine. 2010 Jun 1
• 22 citations
  Drug therapy for hypertriglyceridemia: Fibrates and omega-3 fatty acids
  Peter P. Toth, Thomas D. Dayspring, Gregory S. Pokrywka> ;Current Atherosclerosis Reports. 2009 Jan 1
• 11 citations
  Fibrate therapy in patients with metabolic syndrome and diabetes mellitus.
  Thomas D. Dayspring, Gregory S. Pokrywka> ;Current Atherosclerosis Reports. 2006 Sep 1
• 3 citations
  Radioimmunoassay and immunochemistry of Phaseolus vulgaris phytohemagglutinin: Verification of isolectin subunit structures
  Ronald L. Felsted, Gregory Pokrywka, Chiayu Chen, Merrill J. Egorin, Nicholas R. Bachur> ;Archives of Biochemistry and Biophysics. 1982 Apr 15
• 12 citations
  Comparison of Phaseolus vulgaris cultivars on the basis of isolectin differences
  Ronald L. Felsted, Jean Li, Gregory Pokrywka, Merrill J. Egorin, James F. Spiegel, Roderick M.K. Dale> ;The International Journal of Biochemistry. 1981 Jan 1
• Separation and characterization of Menhaden hemoglobin components.
  Pokrywka, G. S., Gold, F.> ;Hemoglobin. 1980
• Join now to see all

Journal Articles

• Managing to Low-Density Lipoprotein Particles Compared to Low-Density Lipoprotein Cholesterol: A Cost-Effective Analysis  
  Rizzo JA, Mallow PJ, Waters HC, Pokrywka GS, et al, Journal of Clinical Lipidology, 1/1/2013
• The Impact of Triglycerides on Lipid and Lipoprotein Biology in Women  
  Dayspring TD & Pokrywka G, Gender Medicine, 1/1/2010
• Drug Therapy for Hypertriglyceridemia: Fibrates and Omega-3 Fatty Acids  
  P Toth and T Dayspring MD, Current Atherosclerosis Reports, 1/1/2009
• Diagnosis and Treatment of the Metabolic Syndrome in Menopausal Women  
  Gregory Pokrywka, MD, Menopause Management, 11/1/2007
• Pharmacotherapeutic Decisions in Menopausal Women with Cardiovascular Risk  
  T. Dayspring MD and Gregory Pokrywka MD, Future Lipidology, 1/1/2007
• Fibrate Therapy in Patients with Metabolic Syndrome and Diabetes Mellitus  
  T Dayspring MD and G S Pokrywka MD, Current Atherosclerosis Reports, 1/1/2006
• Join now to see all

Books/Book Chapters

• Year in Lipid Disorders 
  Chapter: Triglycerides and Atherosclerosis 
  Dayspring T, Pokrywka GClinical Publishing, Oxford, UK2010

Abstracts/Posters

• Heterogeneity of LDL and HDL Particle Concentrations in Subjects Meeting LDL-Cholesterol Goals.
  James Underberg, MD, Gregory Pokrywka, MD,Hollye Garner, PhD, Ray Pourfarzib, PhD,Deborah Winegar, PhD, Journal of Clinical Lipidology; NLA Scientific Sessions, 6/1/2013

Lectures

• CME Programs & Grand Rounds: "Aggressive Detection and Prevention of ASCVD in Insulin Resistant Women" 
  Multiple locations
• CME Programs & Grand Rounds: "Women's Menopausal Health." 
  Multiple locations

Other

• Radio Interview: "Cardiovascular Risk in PolyCystic Ovarian Syndrome (PCOS) Patients" 
  Gregory Pokrywka, MD
  http://www.pcoschallenge.com
  1/1/2014
• "Beyond LDL in the Prevention and Management of Atherosclerotic Cardiovascular Disease" 
  Gregory Pokrywka, MD, The Maryland Family Doctor
  1/1/2013
• The Role of Fibrates in Patients with Chronic Kidney Disease. 
  Gregory Pokrywka, MD, CME, Foundation for Health Improvement & Technology
  http://www.lecturepad.org/index.php/component/guru/guruPrograms/2-cardiovascular-diabetes-lipids-lipidology-cme/3-the-role-of-fibrates-in-patients-with-chronic-kidney-disease/view/892?task=view
  1/1/2013
• Nonpharmacologic and Complementary Approaches to Lipid Management. 
  Gregory Pokrywka, MD, NLA Lipid Spin
  1/1/2011
• "Statin Use by Women's Health Care Providers" 
  Gregory Pokrywka, MD, North American Menopasue Society "E-Consult"
  1/1/2010
• Are changes in Cardiovascular Risk Factors in Midlife Women due to Chronological Aging or to the Menopausal Transition? 
  Gregory Pokrywka, MD, NAMS Clinician's Corner
  1/1/2010
• "Residual Risk Reduction in Insulin Resistant Patients" 
  Gregory Pokrywka, MD, NLA Lipid Spin
  1/1/2009
• "Beyond Cholesterol. A Special Report on Lipids for Primary Care" 
  Gre (with the National Lipid Assn. Consumer Affairs Committee)
  http://www.learnyourlipids.com
  1/1/2008
• "The Role of Fenofibrate in a Comprehensive Approach for Managing Cardiovascular and Microvascular Complications of Diabetes." 
  Mark J Cziraky, PharmD and Gregory Pokrywka MD, Pharmacy Times, Academy for Continued Healthcare Learning
  10/1/2007
• "The Role of Fenofibrate in Patients with Diabetes: Improving Cardiovascular Outcomes, Microvascular Disease, and Patient Quality of Life." 
  Frank Sacks MD and Gregory Pokrywka MD, Perspectives in Medicine, Academy for Continued Healthcare Learning
  6/1/2007
• Recorded Biodiscussion Lecture: "Hypertriglyceridemia" 
  Dr. Gregory Pokrywka, Dr. Rade Pejic, Dr. Thomas Dayspring, Cardiovascular Forum
  http://www.biodiscussion.com
  4/1/2007
• "Debating Cardiovascular Goals: Raising HDL Cholesterol in Patients with Diabetes" (response). 
  Gregory Pokrywka, MD, Diabetes DOC News
  1/1/2007
• "Cardiovascular Issues in Women" 
  Dr. Thomas Dayspring, Dr. James Underberg, Dr. Gregory Pokrywka, American College of Gynecology UPDATE Volume 32, #3
  9/1/2006
• National Tele-and Web-Conferences: "Aggressive Detection and Prevention of ASCVD in Insulin Resistant Women" 
  Gregory Pokrywka, MD
• National Tele-and Web-Conferences: "Women's Menopausal Health." 
  Gregory Pokrywka, MD
• "Pri-Med Dyslipidemia Lectures (Pages 2008-2103)" 
  Gregory Pokrywka, MD, Atherogenic Dyslipidemia Pocket Guide, Comprehensive Lipoprotein Management to Reduce Residual CVD R
• Join now to see all